Aurinia Pharmaceuticals Inc (STU:IKAP) Stock News, Headlines & Updates
Aurinia Pharmaceuticals Inc Stock News from GuruFocus
- 1
Aug 02, 2024
Aurinia Pharmaceuticals Inc (AUPH) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Positive Cash Flow
GuruFocus Research • 1:04am
Q2 2024 Aurinia Pharmaceuticals Inc Earnings Call Transcript
GuruFocus Research • 11:13pm
Aug 01, 2024
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results
Business Wire • 6:00am
Aurinia Pharmaceuticals (AUPH) Q2 2024 Earnings: EPS of $0.01 Meets Estimates, Revenue of $57.2M Beats Expectations
GuruFocus Research • 5:34am
Jul 19, 2024
Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024
Business Wire • 6:00am
Jul 02, 2024
Aurinia to Participate in Upcoming Investor Healthcare Conferences
Business Wire • 6:00am
Jun 14, 2024
Aurinia Announces 2024 Annual General Meeting Results
Business Wire • 12:00pm
Jun 05, 2024
Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024
Business Wire • 6:00am
Jun 04, 2024
Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce
Business Wire • 5:00pm
Jun 03, 2024
Aurinia Provides Update on Proxy Statement
Business Wire • 6:00pm
May 30, 2024
Aurinia Will Attend 2024 Jefferies Global Healthcare Conference
Business Wire • 6:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news